Silo pharma (silo) announces plans to uplist to the nasdaq

Englewood cliffs, nj, april 22, 2021 (globe newswire) -- silo pharma, inc. (otcqb: silo) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that its board of directors has unanimously voted to uplist to the nasdaq.

SILO Ratings Summary

SILO Quant Ranking